author-photo

Richard FitzGerald

University of Liverpool

10

Papers

62

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Human Mass Balance and Metabolite Profiling of [14 C]-Pamiparib, a Poly (ADP-Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer.

2021 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (1)
An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.

2021 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (4)
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.

2020 The Lancet Diabetes & Endocrinology
Show All
- Source
- Cite
- Save
Citations (27)
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.

2020 Trials
Show All
- Source
- Cite
- Save
Citations (11)
A genome‐wide association study of circulating levels of atorvastatin and its major metabolites

2020 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (9)
Investigating the clinical factors and co‐medications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention

2019 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (7)